Recent National Institutes of Health regulations affecting small businesses
Page 2 of 4 • Last updated April 24, 2026
47 National Institutes of Health regulations have been published in the past 30 days, covering rule changes, notices, and final actions affecting small businesses.
- National Institute on Drug Abuse; Notice of MeetingApril 24, 2026
National Institute on Drug Abuse holds a public meeting to discuss research priorities and funding opportunities for substance abuse prevention and treatment studies.
- Center for Scientific Review; Amended Notice of MeetingApril 23, 2026
Center for Scientific Review will hold an amended meeting of the National Institutes of Health peer review committee on the specified date to address grant application assessments and related administrative matters.
- National Heart, Lung, and Blood Institute; Notice of Open MeetingApril 23, 2026
National Heart, Lung, and Blood Institute open meeting notice provides information about scheduled public sessions for institute business and stakeholder input.
- National Heart, Lung, and Blood Institute; Notice of Closed MeetingApril 23, 2026
National Heart, Lung, and Blood Institute holding a closed meeting to discuss grant applications and administrative matters on the specified date.
- Center for Scientific Review; Notice of Closed MeetingsApril 23, 2026
Center for Scientific Review holds closed meetings for peer review of National Institutes of Health grant applications and related administrative matters.
- Government-Owned Inventions; Availability for LicensingApril 22, 2026
NIAID offers licensing of government-owned inventions from federally funded research to support commercialization by small businesses and companies.
- Government-Owned Inventions; Availability for LicensingApril 22, 2026 • Impact: none
NIAID-owned government inventions are available for licensing to commercialize federally funded research and development, with foreign patent applications filed on selected inventions to extend market coverage.
- Center for Scientific Review; Notice of Closed MeetingApril 21, 2026
Center for Scientific Review holds a closed meeting to discuss grant applications and review panel matters; specific date and location available upon request to authorized personnel.
- National Institute of Dental & Craniofacial Research; Notice of MeetingApril 20, 2026
National Institute of Dental & Craniofacial Research announces an upcoming meeting of its advisory council to review research grant applications and program policies.
- Center for Scientific Review; Notice of Closed MeetingsApril 20, 2026
Center for Scientific Review will hold closed meetings to review federal research grant applications and personnel matters; specific dates and locations listed in Federal Register notice.
- National Center for Advancing Translational Sciences; Notice of MeetingApril 20, 2026
National Center for Advancing Translational Sciences holds a public meeting to discuss biomedical research funding opportunities and translational science initiatives for small research institutions.
- Office of the Director, National Institutes of Health; Notice of MeetingApril 20, 2026
National Institutes of Health Director's office will hold a public meeting to discuss agency policies and strategic initiatives affecting biomedical research funding and grant administration.
- National Institute of Neurological Disorders and Stroke; Notice of MeetingApril 20, 2026
National Institute of Neurological Disorders and Stroke holds a public meeting to discuss research funding priorities and grant opportunities for neurological disease studies.
- National Institute of Neurological Disorders and Stroke; Notice of MeetingApril 20, 2026
National Institute of Neurological Disorders and Stroke announces a public meeting to discuss research funding priorities and grant opportunities for neurological disorder studies.
- Notice of Diabetes Mellitus Interagency Coordinating Committee MeetingApril 20, 2026
The Diabetes Mellitus Interagency Coordinating Committee holds a public meeting on June 24, 2026, to discuss innovative research partnerships in diabetic retinal disease.